Lynn A. Tetrault's Net Worth

$1.74 Million

Estimate Recalculated Dec 4, 2024 04:11PM EST

Who is Lynn A. Tetrault?

Lynn A. Tetrault has an estimated net worth of $1.74 Million. This is based on reported shares across multiple companies, which include RHYTHM PHARMACEUTICALS, INC., NEOGENOMICS INC, and ACELYRIN, Inc..

SEC CIK

Lynn A. Tetrault's CIK is 0001645512

Past Insider Trading and Trends

2024 was Lynn A. Tetrault's most active year for acquiring shares with 9 total transactions. Lynn A. Tetrault's most active month to acquire stocks was the month of May. 2024 was Lynn A. Tetrault's most active year for disposing of shares, totalling 8 transactions. Lynn A. Tetrault's most active month to dispose stocks was the month of July. 2024 saw Lynn A. Tetrault paying a total of $123,157.00 for 111,242 shares, this is the most they've acquired in one year. In 2024 Lynn A. Tetrault cashed out on 49,048 shares for a total of $759,069.31, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

RHYTHM PHARMACEUTICALS, INC. (RYTM) Snapshot price: $49.25

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
$30.77
-$784,298.13
3K
Scheduled
Sep 9 - Sep 10
Form 4
—
0
$34.50
-$133,371.81
3K
Scheduled
Aug 26
Form 4
—
0
$24.40
-$404,961.81
3K
Scheduled
Aug 12
Form 4
∞
3K
—
—
3K
Jun 21
Form 4
—
0
—
—
0
Jun 18
Form 4
—
0
—
—
0
Jun 21
Form 4
—
0
—
—
0
Jun 8
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
Dec 9
Form 3
—
0
—
—
0
No matching records found

NEOGENOMICS INC (NEO) Snapshot price: $16.04

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+22.64%
11.34K
—
—
61.4K
Aug 10
Form 4
—
0
—
—
0
Jun 1
Form 4
-10.88%
-6.11K
$15.97
-$97,578.69
50.06K
Scheduled
Mar 4
Form 4
—
0
—
—
0
Aug 10
Form 4
+2.76%
1.51K
$11.60
$17,481.20
56.17K
May 22
Form 4
+39.77%
15.56K
—
—
54.67K
Jun 10
Form 4
+9.32%
3.33K
$7.27
$24,238.18
39.11K
May 18
Form 4
+2.40%
838
—
—
35.78K
Oct 11
Form 4
+4.14%
1.39K
$9.11
$12,653.79
34.94K
Jun 11
Form 4
+10.11%
3.08K
—
—
33.55K
Jun 2
Form 4
+6.48%
2.7K
—
—
44.35K
May 28
Form 4
+8.94%
3.42K
—
—
41.65K
Jun 6
Form 4
-25.37%
-13.00K
$16.00
-$207,940.00
38.23K
Nov 19
Form 4
+37.19%
13.89K
$11.83
$60,636.96
51.23K
Nov 14 - Nov 15
Form 4
+71.45%
15.56K
—
—
37.35K
Jun 1
Form 4
+49.60%
7.22K
—
—
21.78K
May 25 - May 30
Form 4
—
0
—
—
0
Jul 28
Form 4
+14.77%
2.15K
$7.15
$15,372.50
16.71K
Apr 20
Form 4
+187.75%
9.5K
$8.21
$77,995.00
14.56K
Dec 21
Form 4
+224.36%
3.5K
$7.72
$27,020.00
5.06K
Dec 7
Form 4
—
0
—
—
0
Jul 15
Form 3
—
0
—
—
0
No matching records found

ACELYRIN, Inc. (SLRN) Snapshot price: $4.25

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 7
Form 4
—
0
—
—
0
Dec 18
Form 3
—
0
—
—
0
No matching records found